10 Feb 2020
First AI-generated drug enters clinical trials
By Staff Writer
In 2020, big data and artificial intelligence (AI) will continue to trend as integral parts of the future of pharmaceutical research and healthcare service delivery, GlobalData predicts. The company’s latest annual outlook report, The State of the Biopharmaceutical Industry – 2020, reveals that 65 percent of pharma managers and executives surveyed selected big data (32...
